IBDEI0QL ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11973,0)
 ;;=90732^^48^589^30^^^^1
 ;;^UTILITY(U,$J,358.3,11973,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11973,1,2,0)
 ;;=2^90732
 ;;^UTILITY(U,$J,358.3,11973,1,3,0)
 ;;=3^PNEUMOVAX 23 (PNEUMOCOCCAL VACCINE)
 ;;^UTILITY(U,$J,358.3,11974,0)
 ;;=90658^^48^589^11^^^^1
 ;;^UTILITY(U,$J,358.3,11974,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11974,1,2,0)
 ;;=2^90658
 ;;^UTILITY(U,$J,358.3,11974,1,3,0)
 ;;=3^FLU VACCINE MULTI DOSE VIAL (AFLURIA IIV3)
 ;;^UTILITY(U,$J,358.3,11975,0)
 ;;=90585^^48^589^1^^^^1
 ;;^UTILITY(U,$J,358.3,11975,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11975,1,2,0)
 ;;=2^90585
 ;;^UTILITY(U,$J,358.3,11975,1,3,0)
 ;;=3^BCG VACCINE, PERCUT
 ;;^UTILITY(U,$J,358.3,11976,0)
 ;;=90632^^48^589^18^^^^1
 ;;^UTILITY(U,$J,358.3,11976,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11976,1,2,0)
 ;;=2^90632
 ;;^UTILITY(U,$J,358.3,11976,1,3,0)
 ;;=3^HEP A VACCINE, ADULT IM
 ;;^UTILITY(U,$J,358.3,11977,0)
 ;;=90636^^48^589^19^^^^1
 ;;^UTILITY(U,$J,358.3,11977,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11977,1,2,0)
 ;;=2^90636
 ;;^UTILITY(U,$J,358.3,11977,1,3,0)
 ;;=3^HEP A/HEP B VACC, ADULT IM
 ;;^UTILITY(U,$J,358.3,11978,0)
 ;;=90647^^48^589^22^^^^1
 ;;^UTILITY(U,$J,358.3,11978,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11978,1,2,0)
 ;;=2^90647
 ;;^UTILITY(U,$J,358.3,11978,1,3,0)
 ;;=3^HIB VACCINE, PRP-OMP, IM
 ;;^UTILITY(U,$J,358.3,11979,0)
 ;;=90648^^48^589^23^^^^1
 ;;^UTILITY(U,$J,358.3,11979,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11979,1,2,0)
 ;;=2^90648
 ;;^UTILITY(U,$J,358.3,11979,1,3,0)
 ;;=3^HIB VACCINE, PRP-T, IM
 ;;^UTILITY(U,$J,358.3,11980,0)
 ;;=90649^^48^589^17^^^^1
 ;;^UTILITY(U,$J,358.3,11980,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11980,1,2,0)
 ;;=2^90649
 ;;^UTILITY(U,$J,358.3,11980,1,3,0)
 ;;=3^H PAPILLOMA VACC 3 DOSE IM
 ;;^UTILITY(U,$J,358.3,11981,0)
 ;;=90675^^48^589^34^^^^1
 ;;^UTILITY(U,$J,358.3,11981,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11981,1,2,0)
 ;;=2^90675
 ;;^UTILITY(U,$J,358.3,11981,1,3,0)
 ;;=3^RABIES VACCINE, IM
 ;;^UTILITY(U,$J,358.3,11982,0)
 ;;=90676^^48^589^33^^^^1
 ;;^UTILITY(U,$J,358.3,11982,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11982,1,2,0)
 ;;=2^90676
 ;;^UTILITY(U,$J,358.3,11982,1,3,0)
 ;;=3^RABIES VACCINE, ID
 ;;^UTILITY(U,$J,358.3,11983,0)
 ;;=90680^^48^589^35^^^^1
 ;;^UTILITY(U,$J,358.3,11983,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11983,1,2,0)
 ;;=2^90680
 ;;^UTILITY(U,$J,358.3,11983,1,3,0)
 ;;=3^ROTOVIRUS VACC 3 DOSE, ORAL
 ;;^UTILITY(U,$J,358.3,11984,0)
 ;;=90698^^48^589^4^^^^1
 ;;^UTILITY(U,$J,358.3,11984,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11984,1,2,0)
 ;;=2^90698
 ;;^UTILITY(U,$J,358.3,11984,1,3,0)
 ;;=3^DTAP-HIB-IP VACCINE, IM
 ;;^UTILITY(U,$J,358.3,11985,0)
 ;;=90707^^48^589^28^^^^1
 ;;^UTILITY(U,$J,358.3,11985,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11985,1,2,0)
 ;;=2^90707
 ;;^UTILITY(U,$J,358.3,11985,1,3,0)
 ;;=3^MMR VACCINE, SC
 ;;^UTILITY(U,$J,358.3,11986,0)
 ;;=90710^^48^589^29^^^^1
 ;;^UTILITY(U,$J,358.3,11986,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11986,1,2,0)
 ;;=2^90710
 ;;^UTILITY(U,$J,358.3,11986,1,3,0)
 ;;=3^MMRV VACCINE, SC
 ;;^UTILITY(U,$J,358.3,11987,0)
 ;;=90713^^48^589^31^^^^1
 ;;^UTILITY(U,$J,358.3,11987,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11987,1,2,0)
 ;;=2^90713
 ;;^UTILITY(U,$J,358.3,11987,1,3,0)
 ;;=3^POLIOVIRUS, IPV, SC/IM
